Mar 01, 2018 12:05 pm UTC| Business
SALT LAKE CITY, March 01, 2018 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, continues to demonstrate an unmatched commitment to hereditary cancer risk assessment...
G1 Therapeutics to Present at Investor Conferences in March 2018
Mar 01, 2018 12:04 pm UTC| Business
RESEARCH TRIANGLE PARK, N.C., March 01, 2018 -- G1 Therapeutics, Inc. (Nasdaq:GTHX), a clinical-stage oncology company, today announced that Chief Executive Officer Mark Velleca, M.D., Ph.D., will present a company...
Mar 01, 2018 12:03 pm UTC| Business
BEIJING, March 01, 2018 -- RISE Education Cayman Ltd (NASDAQ:REDU) ("RISE" or the “Company”), a leading junior English Language Training (“ELT”) provider in China, today announced that it plans to release its fourth...
Life On Earth, Inc. Announces Letter to Shareholders
Mar 01, 2018 12:03 pm UTC| Business
NEW YORK, March 01, 2018 -- via OTC PR WIRE -- Life On Earth, Inc. (OTCQB:LFER) (or the “Company”) releases the following shareholder letter: Shareholders of Life On Earth, Inc. Cc: Board of Directors Dear Fellow...
Mar 01, 2018 12:03 pm UTC| Business
Completed submission of NDAs for oral and intravenous omadacycline for the treatment of pneumonia and skin infectionsExpanded medical affairs and payer account management teams in readiness for discussions with formulary...
Mar 01, 2018 12:03 pm UTC| Business
SAN FRANCISCO, March 01, 2018 -- FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the...
Mar 01, 2018 12:03 pm UTC| Business
TORONTO, March 01, 2018 -- NextSource Materials Inc. (TSX:NEXT) (OTCQB:NSRCF) (“NextSource” or “the Company”) will be exhibiting at the 2018 Prospectors Developers Association of Canada (PDAC) International Trade Show ...